Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 13, 2018Fully-automated BD Phoenix(TM) CPO Detect Test Receives U.S. FDA Clearance
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration 510(k) clearance of the BD Phoenix(TM) CPO detect...
-
Nov 6, 2018- As reported, full fiscal year revenues of $15.983 billion increased 32.2 percent.
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.402 billion for the fourth fiscal quarter ended September 30,...
-
Oct 29, 2018
BD MedMined™ Surveillance Advisor has earned Meaningful Use Stage 3 (MU3) certification validating its ability to collect and properly report data around antimicrobial use and resistance data by...
-
Oct 23, 2018Brings Total Company Investment in Nebraska to $340 Million in Two Years
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, was joined today by Gov. Pete Ricketts and other state and local leaders to announce a $200 million...
Oct 17, 2018Company Joins Effort Alongside Rotary and Leading Global Health Organizations to Expand Vaccinations in IndiaBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a donation of 20 million syringes valued at $1 million to Rotary, a nonprofit...
-
Oct 16, 2018BD MAX(TM) MDR-TB Panel Obtains CE-IVD Status in Europe
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the availability of the BD MAX(TM) MDR-TB panel in Europe. Clinicians can use the test...
-
Aug 28, 2018
BD (Becton, Dickinson and Company), Direct Relief, and the National Association of Community Health Centers (NACHC) recently awarded five community health centers with a total of $1 million in...
-
Aug 2, 2018
Click on the links below to view results for the 2018 third fiscal quarter: View document online PDF file of BD 2018 third fiscal quarter results About BD BD is one of the largest global medical...
Jul 26, 2018BD® AbSeq Assay Enables Deeper Understanding of Role Individual Cells Play in the Immune SystemBD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial release of the BD(®) AbSeq assay to analyze protein expression at the...
-
Jul 12, 2018
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2017 Sustainability Performance Update that focuses on four key strategic areas that...